Cited by 284Cell death mechanisms and regulationUbiquitin and proteasome pathwaysNF-κB Signaling Pathways

The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

Open access
Onizawa, Michio, Oshima, Shigeru, Schulze-Topphoff, Ulf, Oses-Prieto, Juan A, Lu, Timothy, Tavares, Rita, Prodhomme, Thomas, Duong, Bao +9 more·2015·Nature Immunology

Abstract

A20 is an anti-inflammatory protein linked to multiple human diseases; however, the mechanisms by which A20 prevents inflammatory disease are incompletely defined. We found that A20-deficient T cells and fibroblasts were susceptible to caspase-independent and kinase RIPK3-dependent necroptosis. Global deficiency in RIPK3 significantly restored the survival of A20-deficient mice. A20-deficient cells exhibited exaggerated formation of RIPK1-RIPK3 complexes. RIPK3 underwent physiological ubiquitination at Lys5 (K5), and this ubiquitination event supported the formation of RIPK1-RIPK3 complexes. Both the ubiquitination of RIPK3 and formation of the RIPK1-RIPK3 complex required the catalytic cysteine of A20's deubiquitinating motif. Our studies link A20 and the ubiquitination of RIPK3 to necroptotic cell death and suggest additional mechanisms by which A20 might prevent inflammatory disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ni.3172

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Major negative regulators of necrosome include STUB1, A20, PPM1B, and AURKA.

    “Major negative regulators of the necrosome include: (1) STIP1 homology and U-box containing protein 1 (STUB1; also known as CHIP), which promotes RIPK1 and RIPK3 ubiquitination followed by lysosomal degradation [472, 473]; (2) A20, which inhibits necrosome assembly by deubiquitinating RIPK3 [473, 474]; (3) protein phosphatase, Mg2+/Mn2+ dependent 1B (PPM1B), which prevents MLKL recruitment to the”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [4]Boone DL The ubiquitin modifiying enzyme A20 is essential for terminating TLR signaling Nat. Immunol 2004 5 1052 1060 15334086
  2. [5]Ma A Malynn BA A20: Linking ubiquitination with immunity and human diseases Nat. Rev. Immunol 2012 12 774 785 23059429 PMC3582397

Cited by

Sorted by citations

Authors
Onizawa, M., Oshima, S., Schulze-Topphoff, U., Oses-Prieto, J. A., Lu, T., Tavares, R., Prodhomme, T., Duong, B., Whang, M. I., Advincula, R., Agelidis, A., Barrera, J., Wu, H., Burlingame, A., Malynn, B. A., Zamvil, S. S., & Ma, A.
Affiliations
  • University of California, San Francisco (US)
  • Tokyo Medical and Dental University (JP)
  • Boston Children's Hospital (US)
Corresponding author
Ma, Averil
Venue
Nature Immunology
Published
2015-05-04
Volume
16
Issue
6
Pages
618-627
ISSN
  • 1529-2908 (ISSN-L)
  • 1529-2916
OpenAlex
W1542400342
Cited by
284
References
51
Citations by year
2026: 17 · 2025: 23 · 2024: 29 · 2023: 16 · 2022: 31 · 2021: 29 · 2020: 26 · 2019: 27 · 2018: 22 · 2017: 24 · 2016: 30 · 2015: 10
FWCI
12.43
Type
journal article
Language
en
Update notices
erratum (2015-06-18)
Open access
Locations
  • Nature Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • Howard Hughes Medical Institute
  • National Multiple Sclerosis Society (RG4768, RG 5180)
  • Crohn's and Colitis Foundation of America
  • Kenneth Rainin Foundation
  • National Institutes of Health
  • University of California, San Francisco
  • National Institute of General Medical Sciences (P41GM103481)
  • National Institute of Allergy and Infectious Diseases (R37AI050872, R01AI117908, T32AI007334, R01AI073737, AI073737, R01AI045937)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK071939, DK095693, R01DK095693, DK071939, P30DK042086, P30DK026743, T32DK007007)
  • National Institute of Neurological Disorders and Stroke (NS063008, R01NS063008)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
A20, RIPK3, necroptosis, ubiquitination, deubiquitinase, caspase-independent cell death, inflammation, anti-inflammatory mechanism, T cells, fibroblasts
MeSH terms
Tumor Necrosis Factor alpha-Induced Protein 3, Animals, Cysteine Endopeptidases, Fibroblasts, Humans, Mice, Inbred C57BL, Necrosis, Protein Binding, T-Lymphocytes, Ubiquitins, Apoptosis, Mice, Knockout, Jurkat Cells, Catalytic Domain, Multiprotein Complexes, Intracellular Signaling Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases, Ubiquitination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review